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formation of spherical aggregates in binuclear
phosphane gold(I) complexes of a bipodal
thiocarbamate dianion: a combined
crystallographic and computational study, and
anti-microbial activity†
Chien Ing Yeo,a Chai-Hoon Khoo,b Wern-Cui Chu,b Bao-Jing Chen,b Pek-Lim Chu,b
Jiun-Horng Sim,b Yoke-Kqueen Cheah,*b Jimmy Ahmad,a Siti Nadiah Abdul Halim,a
Hoi-Ling Seng,c Soon Ng,a A. Otero-de-la-Roza*d and Edward R. T. Tiekink*a
Binuclear phosphanegold(I) complexes of a bipodal thiocarbamate dianion, (R3PAu)2L, R ¼ Et (1), Ph (2) and
Cy (3), where LH2 is {1,4-[MeOC(]S)N(H)]2C6H4}, have been synthesised, and characterised
spectroscopically (NMR and IR) and by X-ray crystallography. The gold atoms are linearly coordinated
within a P-,S-donor set, and are oriented toward the central ring to form intramolecular Au/p(aryl)
interactions, rather than the intramolecular Au/O interactions normally observed in mononuclear
analogues. This phenomenon has been investigated by theory (LC-uPBE-XDM) for 1 which revealed that
the geometry optimised species with two Au/p(aryl) interactions is more stable by at least 12 kcal mol1
compared to conformations having one or more Au/O interactions instead. The disk diﬀusion,
minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) methods were
used to observe the inhibitory eﬀect of complexes 1–3. The disk diﬀusion results demonstrated that 1
exhibited a broad spectrum of anti-bacterial activity toward 24 strains of Gram-positive and Gram-
negative bacteria. By contrast, the anti-bacterial activity of 2 and 3 was limited to Gram-positive bacteria.
Further evaluation showed that 1 exhibited marked bactericidal activity against B. cereus, B. subtilis,
E. faecalis, L. monocytogenes, S. aureus, S. saprophyticus and methicillin resistant S. aureus cf. standard
antibiotics tetracycline and chloramphenicol.Introduction
The structural diversity and the fascinating architectures they
sustain have ensured that aurophilic (Au/Au) interactions have
garnered the attention of chemists for decades.1 The aggrega-
tion of gold compounds in this fashion arises from relativistic
eﬀects which are at a maximum for gold compared to otheralaya, 50603 Kuala Lumpur, Malaysia.
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hemistry 2015heavy elements.2 Over and above aesthetics, interest in gold
compounds/aurophilic interactions stems from their lumines-
cence properties, in both the solid-state and in solution.3 By
contrast to aurophilic interactions, the recognition of supra-
molecular association based on Au/p(aryl) interactions is still
in its infancy,4a despite them being oen crucial in the reaction
mechanisms related to the burgeoning eld of gold-based
catalysis.5 It is only in recent years that bibliographic surveys
have shown that Au/p(aryl) interactions provide readily iden-
tiable points of contact between molecules in their crystal
structures, operating in isolation of other supramolecular
synthons.4
The themes of aurophilic and Au/p(aryl) interactions as
well as luminescence feature prominently in the chemistry of
phosphanegold(I) thiocarbamates, where the thiolate anion is
derived from thiocarbamide molecules of the general formula
RN(H)C(]S)OR0, R,R0 ¼ alkyl and/or aryl.6 In the overwhelming
majority of crystal structures of phosphanegold(I) thio-
carbamates, the thiolate ligand is oriented so that the oxygenRSC Adv., 2015, 5, 41401–41411 | 41401
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View Article Onlineatom is located in close proximity to the gold atom. However, by
careful choice of R and R0 substituents of the thiolate anion and
by using isomeric tolylphosphane ligands, it proved possible to
orient the thiolate so that the aryl ring was proximate to the gold
atom instead.6c Crystal engineering considerations notwith-
standing, phosphanegold(I) thiocarbamates also exhibit prom-
ising biological activity.
Gold(I) compounds are used clinically in the treatment of
severe forms of rheumatoid arthritis, being a member of the
disease modifying anti-rheumatic drugs (DMARDS) class of anti-
arthritic agents.7a–c Spurred by the observation that patients
undergoing chrysotherapy, appeared to suﬀer reduced rates of
malignant disease,7d both gold(I) and gold(III) compounds are
under intense investigation as potential anti-tumour drugs.8 In
the context of the present study, phosphanegold(I) thiocarbamates
of the general formula Ph3PAu[SC(OR)]NPh], R¼Me, Et and iPr,
exhibit signicant cytotoxicity toward HT-29 colon cancer cells,
have been shown to function through both intrinsic and extrinsic
apoptotic pathways, and to be topoisomerase I inhibitors.9 Gold
compounds are also under active evaluation as anti-microbial
agents.10 Recently, another series of phosphanegold(I) thio-
carbamates, namely Ph3PAu[SC(OR)]N(p-tol)], R ¼ Me, Et and
iPr, have proven to be very eﬀective against a panel of Gram-
positive bacteria.11
It was primarily the biological context that led to the
synthesis of the title binuclear compounds, (R3PAu)2L, R ¼ Et
(1), Ph (2) and Cy (3), where LH2 is the bipodal molecule {1,4-
[MeOC(]S)N(H)]2C6H4}. Herein, their characterization,
including by X-ray crystallography and Density Functional
Theory (DFT) calculations is described along with an evaluation
of their potential anti-microbial activity.
Experimental section
Materials, methods and Instruments
All chemicals and solvents were used as purchased without
purication. All reactions were carried out under ambient
conditions. Elemental analyses were performed on a Perkin
Elmer PE 2400 CHN Elemental Analyser. Melting points were
determined on a Kru¨ss KSP1N melting point meter. 1H and 13C
{1H} NMR spectra were recorded in both DMSO-d6 and CDCl3
solutions for LH2, and CDCl3 solutions for 1–3 on a Bruker
Avance 400 MHz NMR spectrometer with chemical shis rela-
tive to tetramethylsilane. 31P{1H} NMR spectra were recorded in
CDCl3 solution on the same instrument but with the chemical
shis recorded relative to 85% aqueous H3PO4 as the external
reference; abbreviations for NMR assignments: s, singlet; d,
doublet; m, multiplet; dq, doublet of quartets; dt, doublet of
triplets. For the relaxation experiments on 1, a solution of the
compound (20 mg) was prepared in CDCl3 (4.5 cm) in a 5 mm
NMR tube (Wilmad). The solution was degassed through ve
freeze–pump–thaw cycles and sealed under vacuum. The NMR
measurements were carried out on a JEOL ECX500 NMR spec-
trometer. The 13C spin–lattice relaxation time (T1) was obtained
by using the two-pulse inversion–recovery (IR) method.12
Initially, an approximate T1 value was obtained before a more
precise measurement was made using 10 IR intervals in a range41402 | RSC Adv., 2015, 5, 41401–41411up to 1.5T1. Subsequently, a nal measurement was made to
conrm the value T1 ¼ 0.69 s at 20 C. Then, the NOE
measurements were made in two consecutive experiments: one
with complete proton decoupling with a relaxation delay of 6.0 s
and an acquisition time of 1.04 s, and the other experiment with
gated-decoupling in which the NOE was suppressed but with
the remaining conditions the same as in the rst experiment.
The pulse angle was 90. Good signal intensity was obtained
with 1024 scans. The total integrated intensity of the signal was
obtained with the spectrometer's data processing soware. The
ratio of the signal intensities in the two experiments gives the
NOE value, usually given as NOE ¼ 1 + h, where h is the NOE
enhancement factor. IR spectra were measured on a Perkin
Elmer Spectrum 400 FT Mid-IR/Far-IR spectrophotometer from
4000 to 400 cm1; abbreviations: vs, very strong; s, strong; m,
medium; br, broad. Thermogravimetric analyses were per-
formed on a Perkin Elmer TGA 4000 Thermogravimetric
Analyzer in the range of 35–850 C at the rate of 10 C min1.
Powder X-ray diﬀraction (PXRD) data were recorded with a
PANalytical Empyrean XRD system with Cu-Ka1 radiation
(l ¼ 1.54056 A˚) in the 2q range 5 to 50. The comparison
between experimental and calculated (from CIF's) PXRD
patterns were performed with X'Pert HighScore Plus.13
Synthesis of LH2. LH2 was prepared in similar manner as
described in the literature for mono-functional analogues14
whereby p-phenylene diisothiocyanate (2.50 mmol, 0.48 g;
Sigma-Aldrich) was reacted in MeOH (100 ml) in the presence of
two mole equivalents of NaOH, yielding a pale-yellow powder.
Yield: 0.596 g (93%). mp 209.0–210.0 C. Anal. calc. for
C10H12N2O2S2: C, 46.85; H, 4.72; N, 10.93. Found: C, 46.71; H,
4.64; N, 10.94%. IR (n, cm1): 3219 (br) n(N–H), 1454 (s) n(C–N),
1140 (s) n(C–O), 1046 (s) n (C]S). 1H NMR (DMSO-d6): d 11.10 [s,
br, 2H, NH], 7.59 [s, br, 2H, aryl-H], 7.30 [s, br, 2H, aryl-H], 3.99
[s, 6H, OCH3] ppm.
1H NMR (CDCl3): d 8.32 [s, br, 2H, NH], 7.56
[s, br, 2H, aryl-H], 7.22 [s, br, 2H, aryl-H], 4.12 [s, 6H, OCH3]
ppm. 13C{1H} NMR (DMSO-d6): d 189.1, 188.4 [Cq], 135.8, 134.8
[Cipso], 123.7 and 122.6 [Cortho], 58.3, 56.8 [OCH3] ppm.
Synthesis of (R3PAu)2L, R ¼ Et (1), Ph (2) and Cy (3). The
methods employed for the preparation and recrystallization of
1–3 were similar, so the preparation of the Et3P derivative (1) is
described in detail as a representative example. The R3PAuCl, R
¼ Et, Ph and Cy, precursors employed in the synthesis were
prepared following standard procedures by reducing KAuCl4
(Sigma-Aldrich) using one mole excess sodium sulte (Merck),
and then further reacted with onemole equivalent of either Et3P
(Merck), Ph3P (Merck) or Cy3P (Sigma-Aldrich), to yield the
respective precursor.
(Et3PAu)2L (1). NaOH (0.50 mmol) in water (5 ml) was added
to a suspension of Et3PAuCl (0.50 mmol) in acetonitrile (20 ml)
followed by addition of LH2 (0.25 mmol) in acetonitrile (20 ml).
The resulting mixture was stirred for 3 h at 50 C. Extraction
followed with dichloromethane (100 ml) and an equivalent
volume of acetonitrile added. The solution was le for slow
evaporation at room temperature, giving colourless crystals
aer 2 weeks. Yield: 0.206 g (93%). mp 174.0–176.0 C. Anal.
calc. for C22H40Au2N2O2P2S2: C, 29.87; H, 4.56; N, 3.17. Found:
C, 29.92; H, 4.53; N, 3.04%. IR (cm1): 1421 (m) n(C]N),This journal is © The Royal Society of Chemistry 2015
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View Article Online1123 (vs) n(C–O), 1094 (s) n(C–S). 1H NMR (CDCl3): d 6.72 [s, 4H,
aryl-H], 3.81 [s, 6H, OCH3], 1.70 [dq, 12H, CH2P,
3JHH¼ 7.75, 2JPH
¼ 9.82Hz], 1.06 [dt, 18H, CH3CH2P, 3JHH¼ 7.62, 3JPH¼ 18.32 Hz]
ppm. 13C{1H} NMR (CDCl3): d 165.3 [Cq], 145.7 [aryl, Cipso], 122.8
[aryl, Cortho], 55.2 [OCH3], 17.6 [d, CH2P
1JCP ¼ 33.3 Hz], 8.8 [s,
CH3CH2P] ppm.
31P{1H} NMR (CDCl3): d 35.6 ppm.
(Ph3PAu)2L (2). A similar synthetic procedure as employed for
1 was used for the synthesis of 2 except that the gold precursor
was replaced by Ph3PAuCl. Colourless crystals. Yield: 0.255 g
(87%). mp 181.5–183.0 C. Anal. calc. for C46H40Au2N2O2P2S2: C,
47.11; H, 3.44; N, 2.39. Found: C, 47.25; H, 3.31; N, 2.41%. IR
(cm1): 1434 (s) n(C]N), 1143 (s) n(C–O), 1101 (s) n(C–S). 1H
NMR (CDCl3): d 7.49–7.41 [m, 30H, Ph3P], 6.41 [s, 4H, aryl-H],
3.73 [s, 6H, OCH3] ppm.
13C{1H} NMR (CDCl3): d 163.2 [Cq],
145.7 [aryl, Cipso], 134.4 [d, o-Ph3P,
2JCP ¼ 13.9 Hz], 131.4 [d,
p-Ph3P,
4JCP ¼ 2.2 Hz], 129.6 [d, i-Ph3P, JCP ¼ 57.0 Hz], 128.9 [d,
m-Ph3P,
3JCP¼ 11.5 Hz], 122.4 [aryl, Cortho], 55.0 [OCH3] ppm. 31P
{1H}NMR (CDCl3): d 38.1 ppm.
(Cy3PAu)2L (3). The synthesis was as for 1 but using Cy3PAuCl.
Colourless crystals. Yield: 0.275 g (91%). mp 180.0–181.0 C.
Anal. calc. for C46H76Au2N2O2P2S2: C, 45.69; H, 6.34; N, 2.32.
Found: C, 45.57; H, 6.40; N, 2.24%. IR (cm1): 1444 (s) n(C]N),
1130 (s) n(C–O), 1093 (m) n(C–S). 1H NMR (CDCl3): d 6.84 [s, 4H,
aryl-H], 3.82 [s, 6H, OCH3], 1.98–1.20 [m, 66H, Cy3P] ppm.
13C
{1H} NMR (CDCl3): d 163.9 [Cq], 145.4 [aryl, Cipso], 122.4 [aryl,
Cortho], 54.8 [OCH3], 33.3 [d, 1-Cy3P, JCP ¼ 27.8 Hz], 30.7 [s,
3-Cy3P], 27.0 [d, 2-Cy3P,
3JCP¼ 11.9 Hz], 25.9 [s, 4-Cy3P] ppm. 31P
{1H}NMR (CDCl3): d 56.5 ppm.
X-ray data collection and structure determination
Intensity data were measured at 100 K on an Agilent Technol-
ogies SuperNova Dual CCD with an Atlas detector tted with Mo
Ka radiation (l ¼ 0.71073 A˚). Data processing and absorption
correction were accomplished with CrysAlis PRO.15a With the
use of SHELX programs15b integrated into WinGX,15c the struc-
tures were solved by direct methods and rened on F2 by full-
matrix least-squares with anisotropic displacement parame-
ters for all non-hydrogen atoms. The C-bound H atoms were
placed on stereochemical grounds and rened in the riding
model approximation with Uiso ¼ 1.2–1.5Ueq(carrier atom). A
weighting scheme of the form w ¼ 1/[s2(Fo2) + (aP)2 + bP] where
P¼ (Fo2 + 2Fc2)/3 was introduced in each case. For 1, the residual
electron density peaks were located 0.95 and 0.96 from the Au
atom, and for 2, the peaks were 0.90 and 0.86 from the Au atom.
Details of cell data, X-ray data collection and structure rene-
ment are given in Table 1. The programs ORTEP-3 for Win-
dows,15c PLATON,15d DIAMOND15e and QMol15f were also used in
the analysis.
Powder X-ray diﬀraction
Powder X-ray patterns (PXRD) measured on the bulk material
for each of 1–3 were compared with the simulated patterns
calculated based on the CIF's obtained for the experimental
crystal structures.13 There is a high agreement between the
patterns, ESI Fig. S1,† suggesting the single crystal results are
representative of the bulk materials.This journal is © The Royal Society of Chemistry 2015Computational study
The calculations were run using Gaussian09 (ref. 16) and the
LC-uPBE17 functional combined with the exchange-hole dipole
moment (XDM) model dispersion correction,18–20 implemented
in the postg program.21 In a previous contribution, it was shown
that LC-uPBE-XDM gives excellent performance in the treat-
ment of aurophilicity,22 so it is a reasonable choice to study
interactions involving gold. Three conformations were examined
for 1: (i) the same conformation as in the crystal structure, with
two Au/p(aryl) contacts, (ii) a mixed conformation with one
Au/p(aryl) and one Au/O contact, i.e. where one Au/p(aryl)
interaction of the experimental structure was replaced by a
contact between gold and a thiocarbamate-O atom, and (iii) the
fully extended, rod-like conformations with two Au/O interac-
tions. The geometry of each conformer was relaxed using the 6-
31+G* basis set for all s- and p-block elements and aug-cc-pVDZ-
PP scalar relativistic pseudo-potential and basis set combination
for Au.23 Despite the modest size of this basis set, it has been
shown in previous work that just one set of diﬀuse and polari-
zation functions is suﬃcient to model non-covalent interactions
with an accuracy relatively close to the basis-set limit.24Anti-microbial assay
Bacterial strains. The standard reference strains of bacteria
used in the present study were Aeromonas hydrophila (A. hydro-
phila) ATCC 35654, Acinetobacter baumannii (A. baumannii)
ATCC 19606, Bacillus cereus (B. cereus) ATCC 10876, Bacillus
subtilis (B. subtilis) ATCC 6633, Citrobacter freundii (C. reundii)
ATCC 8090, Enterobacter cloacae (E. cloacae) ATCC 35030,
Enterobacter aerogenes (E. aerogenes) ATCC 13048, Enterococcus
faecalis (E. faecalis) ATCC 29212, Enterococcus faecium (E. fae-
cium) ATCC 19434, Escherichia coli (E. coli) ATCC 25922, Klebsi-
ella pneumoniae (K. pneumoniae) ATCC 700603, Listeria
monocytogenes (L. monocytogenes) ATCC 19117, Proteus mirabilis
(P. mirabilis) ATCC 25933, Proteus vulgaris (P. vulgaris) ATCC
13315, Pseudomonas aeruginosa (P. aeruginosa) ATCC 27853,
Salmonella paratyphi A (S. paratyphi A) ATCC 9150, Salmonella
typhimurium (S. typhimurium) ATCC 14028, Shigella exneri (S.
exneri) ATCC 12022, Shigella sonnei (S. sonnei) ATCC 9290,
Staphylococcus aureus (S. aureus) ATCC 25923, methicillin
resistant Staphylococcus aureus (MRSA) ATCC 43300, Staphylo-
coccus saprophyticus (S. saprophyticus) ATCC 15305, Steno-
trophomonas maltophilia (S. maltophilia) ATCC 13637 and Vibrio
parahaemolyticus (V. parahaemolyticus) ATCC 17802. All bacte-
rial strains were purchased from the American Type Culture
Collection (ATCC, Manassas, VA, USA).
Anti-bacterial activity. The anti-bacterial activity of 1–3 was
evaluated using the Kirby–Bauer disc diﬀusion method in
accordance with the National Committee for Clinical Labora-
tory Standards (NCCLS) guidelines. The bacterial cultures were
adjusted to 0.5 McFarland standard turbidity (which corre-
sponds to approximately 108 CFU ml1) by adding Mueller-
Hinton broth (Difco, USA). This suspension was then swabbed
onto the surface of Mueller-Hinton agar (Difco, USA) plates. The
tested compounds were dissolved in DMSO to a test concen-
tration of 2 mg ml1. Sterile 6 mm lter paper discs wereRSC Adv., 2015, 5, 41401–41411 | 41403
Table 1 Crystal data, data collection and reﬁnement parameters for compounds 1–3
1 2 3
Formula C22H40Au2N2O2P2S2 C46H40Au2N2O2P2S2 C46H76Au2N2O2P2S2
Formula weight 884.56 1172.79 1209.08
Crystal size (mm) 0.10  0.20  0.25 0.20  0.20  0.30 0.20  0.30  0.30
Crystal system Monoclinic Triclinic Monoclinic
Space group P21/c P1 P21/n
a/A˚ 6.8843(6) 8.9980(4) 9.7522(3)
b A˚ 11.6056(7) 9.0501(4) 12.2227(3)
c/A˚ 17.7118(10) 14.2542(6) 19.9917(5)
a/ 90 107.851(4) 90
b/ 94.244(6) 100.439(4) 93.683(3)
g/ 90 100.556(4) 90
V/A˚3 1411.23(17) 1050.66(8) 2378.05(11)
Z 2 1 2
Dx/g cm
3 2.082 1.854 1.689
m/mm1 10.667 7.190 6.355
q range/ 2.9–27.5 3.0–27.5 2.8–27.5
Reections measured 15 284 12 872 26 714
Independent reections; Rint 3218; 0.030 4751; 0.054 5408; 0.032
Reections with I > 2s(I) 2955 4433 4894
Number of parameters 149 254 254
R(F) [I > 2s(I) reections] 0.025 0.024 0.021
a, b in weight scheme 0.031, 3.103 0.008, 0 0.010, 1.698
wR(F2) (all data) 0.064 0.044 0.041
GOF(F2) 1.08 0.97 1.05
Drmax,min (e A˚
3) 1.71, 1.46 1.12, 1.31 0.59, 0.61
Table 2 Variable temperature 1H NMR data (d, ppm; W1/2, band width
at half-height) for LH2 recorded in DMSO-d6 solution
Temp. (C) NH aryl-H Ome W1/2 (Hz)
28 11.08 7.59, 7.29 3.98 29.32
38 11.04 7.57, 7.31 3.98 12.40
48 10.99 7.41 3.98 6.52
58 10.95 7.44 3.99 4.95
68 10.90 7.44 3.99 (sh, 3.98) 3.17
78 10.86 7.44 4.00 (sh, 3.98) 2.29
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View Article Onlineaseptically placed on Mueller-Hinton agar surfaces and 5 ml of
the dissolved compounds were immediately added to discs.
DMSO was used as a negative control whereas standard anti-
biotic paper disc was used as the positive control. All plates
were incubated at 37 C for 24 h. The anti-bacterial activity was
evaluated by measuring the diameter of the inhibition zone
against the test bacterial strains. Each trial was performed in
triplicate.
Minimum inhibitory concentration (MIC) and minimum
bactericidal concentration (MBC) determination. The MIC was
determined by the broth micro-dilution method according to
the NCCLS guidelines. An inoculum suspension with a density
105 CFUml1 of exponentially growing bacterial cells was added
into each well. The test compounds were serially two-fold
diluted in DMSO and then added to each well of a 96-well
microplate. The 96-well microplates were incubated at 37 C for
24 h. All tests were performed in triplicate. Four controls
comprisingmediumwith standard anti-biotic (positive control),
medium with DMSO (solvent control), medium with inoculum
bacterial cells (negative control) and medium with broth only
(negative growth control) were included in each test. The
bacterial growth was detected by adding 50 ml of a 0.2 mg ml1
p-iodonitrotetrazolium violet (INT) indicator solution into each
of the microplate wells and incubated at 37 C for 30 min. under
aerobic agitation. The INT changed from clear to red in the
presence of bacterial activity. Where bacterial growth was
inhibited, the suspension in the well remained clear aer
incubation with INT. The lowest concentration of the tested
compound which completely inhibited bacterial growth was
taken as the MIC. Aer MIC determination of each tested41404 | RSC Adv., 2015, 5, 41401–41411compound, an aliquot of 100 ml from each well which showed
no visible growth was spread onto MHA at 37 C for 24 h. The
MBC is dened as the lowest concentration of the tested
compound at which bacteria are killed.
Results and discussion
Syntheses and spectroscopy
The reaction of p-phenylene di-isothiocyanate with MeOH in the
presence of base yielded bipodal LH2 in high yield. The
1H and,
especially, 13C NMR of LH2 showed unexpected features in that
chemically equivalent sites gave multiple resonances. Accord-
ingly, a variable temperature 1H NMR study in DMSO-d6 solution
(to attain a wider temperature range) was conducted with the
results summarised in Table 2. Two resonances were observed
for the ring protons when equivalence might have been expec-
ted. The splitting is ascribed to the formation of intramolecular
methyl-C–H/p(aryl) interactions rendering the protonsThis journal is © The Royal Society of Chemistry 2015
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View Article Onlineinequivalent. Upon heating the solution, the two signals coa-
lesced into a single resonance, most likely due to rapid exchange,
ESI Fig. S2a.† While no splitting was observed for the resonance
due to the methyl protons, marked sharpening of the signal was
evident as manifested in the W1/2 values of 29.32 Hz at 28 C cf.
2.29 Hz at 78 C, indicative of a rapid exchange process, ESI
Fig. S2b.† This was accompanied by a small downeld shi. The
N-bound proton shied upeld with increasing temperature
consistent with reduced hydrogen bonding with the solvent.
Evidence that the reduction in hydrogen bonding was a two-step
process was found in the appearance of a shoulder for the
methyl-proton at 68 C consistent with the appearance of a
minor, new species. The two environments arise at high
temperature as one N-bound proton is involved in hydrogen
bonding with the solvent and the other is not, cf. both partici-
pating in hydrogen bonding at low temperature.
Upon deprotonation and coordination of LH2, the
1H NMR
resonance at 8.32 (CDCl3) ascribed to N–H no longer persists in
the spectra of 1–3. By contrast to the spectrum recorded for LH2,
all chemically equivalent nuclei resonated at the same eld
strength. Also noteworthy are the signicant upeld shis in the
resonances due to aryl-H of the central ring, i.e. to 6.72, 6.41 and
6.84 for 1–3, respectively cf. 7.56 and 7.22 observed for LH2. This
observation is correlated with the presence of intramolecular
Au/p(aryl) interactions as delineated by X-ray crystallography
(see below). The key nding of the 13C{1H} NMR spectra was that
the four phenyl hydrogen-bearing nuclei, ortho and meta, are
equivalent and appear as a single resonance in CDCl3 solution.
Similarly, the quaternary ipso carbons are also equivalent. In the
31P NMR, a single resonance was observed for 1–3 at 35.6, 38.1
and 56.5, respectively, which are deshielded with respect to the
uncoordinated Et3P (20.0), Ph3P (5.2) and Cy3P (9.2) molecules
measured under the same conditions. The relaxation attributes of
1, being representative of the series, were also investigated.
In the 13C{1H} NMR spectrum of 1, the ortho and meta
carbons of the central ring resonated at d ¼ 122.84 ppm. At
20 C in CDCl3 solution, the observed
13C spin-lattice relaxation
time (T1) for this resonance was 0.69 s, and the NOE ¼ 2.88; the
NOE enhancement factor, h, was 1.88. As this h value is very
near the maximum value of 1.988 for a 13C nucleus, the domi-
nant relaxation mechanism is the dipole–dipole relaxation
mechanism (Tdd1 ), for which the rate of this dipolar relaxation (1/
Tdd1 ), is proportional to the correlation time.12,25 The observed T1
is very low for phenyl nuclei in solution and is consistent with
very low mobility of the phenyl group in the molecule. Hence,
the observed 13C relaxation data are consistent with severe
hindrance in the internal rotation of the phenyl group.
The IR spectra of compounds 1–3 conrmed the absence of
broad absorption at 3219 cm1, due to n(N–H) in LH2. Further,
the red shis of the n(C–N) absorption to1400 cm1, and blue
shis of n(C]S) to 1100 cm1 in 1–3 when compared to LH2
provide further evidence for complexation.Fig. 1 Perspective views of the molecules of (a) 1, (b) 2 and (c) 3.
Displacement ellipsoids are drawn at the 70% probability level and
hydrogen atoms are shown as small spheres of arbitrary radii. The
unlabelled atoms in (a) are related by the symmetry operation 1  x,
2  y, z, and in (b) and (c) by 1  x, 1  y, z.Crystallography
The crystal structures of 1–3 were established by X-ray crystal-
lography: the molecular structures are shown in Fig. 1 andThis journal is © The Royal Society of Chemistry 2015selected geometric parameters are collated in Table 3. The
molecule in 1, Fig. 1a, is located about a centre of inversion and
features a linear gold atom geometry dened by the phosphane-
P and thiolate-S atoms. As usual for this type of structure,6 the
Au–S bond length is longer than that of Au–P. As the crystalRSC Adv., 2015, 5, 41401–41411 | 41405
Table 3 Selected bond lengths (A˚) and angles () for 1–3
1 2 3
Au–S1 2.3152(10) 2.3058(9) 2.3019(6)
Au–P1 2.2663(10) 2.2593(9) 2.2695(6)
C1–S1 1.762(4) 1.761(3) 1.756(3)
C1–O1 1.372(5) 1.356(4) 1.362(3)
C1–N1 1.258(5) 1.268(4) 1.263(3)
S1–Au–P1 172.13(4) 167.79(3) 168.63(2)
Au–S1–C1 107.07(14) 107.37(12) 111.77(9)
C1–N1–C3 123.5(4) 122.3(3) 124.8(2)
S1–C1–O1 108.5(3) 108.1(2) 106.82(17)
S1–C1–N1 132.8(3) 131.3(3) 134.3(2)
O1–C1–N1 118.7(4) 120.6(3) 118.8(2)
Au/Cg(aryl)a 3.26 3.32 3.55
aa 22.7 21.6 30.7
a a is the angle between the normal to the plane through the central ring
and the vector passing through the centroid (Cg) of the aryl ring to the
Au atom.
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View Article Onlinestructure of the precursor thiocarbamide, LH2, is not available,
the comparison between the geometric parameters dening the
thiolate ligand in 1 will be made with PhN(H)C(]S)OMe.26 The
most notable observations is the elongation of the C1–S1 and
contraction of the C1–N1 bond lengths in 1, Table 1, compared
with 1.6708(11) and 1.3288(15) A˚, respectively in the uncoordi-
nated molecule.26 These changes are consistent with L2 coor-
dinating each gold atom as a thiolate ligand. The
rearrangement of electron density in the anion also results in
signicant diﬀerences in bond angles whereby the S1–C1–O1
angle has contracted by about 16, and the S1–C1–N1 and
O1–C1–N1 angles have expanded by about 10 and 6, respec-
tively, observations readily correlated with the increased elec-
tron density in the C1–N1 bond. The molecular structures of 2
and 3 have essentially the same features as described for 1, as
highlighted in the overlay diagram shown in Fig. 2 that shows
only small conformational variations. According to a search of
the Cambridge Structural Database (CSD),27 there are noFig. 2 Overlay diagram of 1 (red image), 2 (green) and 3 (blue). No
hydrogen atoms are shown and only the a-carbon atoms of the
phosphane ligands are included. The molecules have been overlapped
so that the central rings are coincident.
41406 | RSC Adv., 2015, 5, 41401–41411precedents for binuclear structures based on bipodal thio-
carbamates or analogues of higher denticity.
The crystal packing of 1 is devoid of directional intermolec-
ular interactions andmay be described as comprising columns of
molecules parallel to the a-axis, ESI Fig. S3a.†Weak C–H/p(aryl)
interactions are noted in the crystal packing of 2, and methylene-
C–H/O contacts are seen in 3. Despite these and the disparity in
space groups, Table 1, the packing for each of 2 and 3 is as
described for 1, i.e. comprising columns of molecules aligned
along the a-axis, ESI Fig. S3b and c.†
The linear coordination geometries for gold deviate by up to
12 from the ideal, deviations that are ascribed to the presence
of intramolecular Au/p(aryl) interactions, Table 3. Such
deviations are usually observed in related mononuclear
structures of [MeOC(S)]NR] but more oen than not due to
intramolecular Au/O interactions. Indeed, of the 31 struc-
tures available in the CSD27 with the general formula, R3PAu
[SC(OMe)]NR0], and diphosphane analogues,6a,28 27 feature
Au/O interactions in the range 2.862(3) A˚ for R ¼ Ph &
R0 ¼ p-tol,6c to 3.172(8) A˚ for R ¼ Cy & R0 ¼ p-NO2Ph.6a The
remaining structures, each with isomeric tol3P ligands, were
reported to form intramolecular Au/p(aryl) interactions in
the absence of steric hindrance and by judicious combinations
of R and R0 groups.6c Given that in no circumstances were
intramolecular Au/p(aryl) interactions formed for R3P
ligands with R ¼ Et, Ph or Cy, the observation of these inter-
actions in 1–3 was unexpected. The ckle nature of the
formation of Au/p(aryl) interactions is probably best illus-
trated in the polymorphs of dppm(AuCl)2 where in one form, an
intramolecular Au/Au interaction is formed within an A-frame
arrangement,29a whereas in the other polymorph, an intra-
molecular Au/p(aryl) interaction was observed instead.29b In
order to probe further the nature of the Au/p(aryl) interactions
formed in 1–3, 1 was subjected to a computational study.Optimised molecular structures
Phosphanegold(I) thiolates sometimes present unexpected
structures.30 For example, in structures of the type R3PAu
[SC(]S)OR0], R,R0 ¼ alkyl/aryl, intramolecular Au/O interac-
tions are usually formed giving rise to compact structures,
rather than the intramolecular Au/S contacts expected from
hard acid/so base considerations. The latter interactions lead
to open, rod-like molecular structures.30a–c In a similar vein, in a
related species, i.e. Cy3PAu[SC6H4-2-CO2H], in one polymorph
the anticipated eight-membered {.HOCO}2 synthon is formed,
linking molecules in the crystal structure to form rod-type
conformations. However, in each of the three other poly-
morphs, intramolecular O–H/S(thiolate) hydrogen bonds are
formed instead, leading to spherical molecules.30d,e The unex-
pected structures were rationalised in terms of global crystal
packing considerations,31 in that the packing of spherical
aggregates is more eﬃcient that the packing of “rods”.30
Geometry optimisation calculations were performed on 1 with
the energy minimised structure having a conformation very
similar to the experimentally observed structure. As highlighted
in Fig. 3, there has been a attening in the N]C–S–Au part of theThis journal is © The Royal Society of Chemistry 2015
Fig. 4 Calculated structures for 1: (a) the compact, spherical,
conformation with two intramolecular Au/p(aryl) interactions, (b)
intermediate structure with one Au/p(aryl) and one Au/O contact,
and (c) the open, rod-like, conformation with two Au/O interactions.
Bader0s delocalization indices between gold (in orange) and all other
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View Article Onlinegeometry optimised molecule as manifested in the N1–C1–S1–Au
dihedral angle of0.9, cf. 14.8(5) in the experimental structure.
Conformational diﬀerences are also noted in the phosphane-
bound ethyl groups. Further, the calculations show that the
conformation presenting two intramolecular Au/p(aryl)
contacts, as is experimentally observed in the crystal structure of
1, is more stable by 12.2 kcal mol1 with respect to the confor-
mation featuring one Au/p(aryl) contact and one Au/O contact,
and by 23.6 kcal mol1 than the rod-like conformer with two Au/
O interactions, Fig. 4. These results shown the Au/p(aryl)
interaction is much stronger than Au/O, and roughly additive.
The Bader delocalization indices (DI's)32 were calculated at
the LC-uPBE-XDM level between gold and the rest of the atoms
in the three studied conformations. Intermolecular DI's are an
excellent tool to evaluate the degree of electron delocalization
(charge transfer) between interacting fragments.33 For the
conformations featuring Au/p(aryl) interactions, there is a
signicant amount of electron sharing between the gold atoms
and the central ring, indicating the existence of orbital inter-
actions between the gold atom and the p-system, and justifying
the high stability of this contact, Fig. 4. The DI between the two
gold atoms and the aryl ring is 0.56 in the compact conformer
and 0.29 in the mixed Au/p(aryl)/Au/O conformer. The
degree of electron delocalization between Au and the
thiocarbamate-O atom in the Au/O contact is relatively small
in comparison (0.10), although larger than the DI with the
atoms adjacent to the oxygen, which indicates an interaction
weaker than Au/p(aryl), in agreement with the energies. In
addition, the S–Au–P angle is linear for the Au/O contact but
bends slightly (170) when a Au/p(aryl) contact is present,
indicating a steric clash between the P-bound ethyl groups and
the central ring. Despite this steric clash, the large stabilization
caused by electron delocalization across the intramolecular
Au/p(aryl) contact is clearly responsible for the conformation
adopted in the crystal structure.individual atoms are given as a colour scale ranging from zero (white)
to 0.30 (red).Thermogravimetric analysis
Traces for the thermogravimetric analysis for 1–3 are given in
ESI Fig. S4.† The decomposition pathways are quite similar forFig. 3 Overlay diagram of the experimental molecular structure of 1
(red image) and the energy minimised structure (black). The molecules
have been overlapped so that the central rings are coincident.
This journal is © The Royal Society of Chemistry 20151–3 and the following sequence is proposed. For 1, three
discernible steps were resolved: step 1 – onset temperature
181.9 C to end 226.9 C resulted in a weight loss of 73.3%
cf. 70.7% corresponding to the loss of 2Et3P. The second step
(226.9–441.8 C) saw a weight loss of 18.0% cf. 21.5%, correlated
with loss of (2L–2S) leaving 2AuS (obs., calcd weight remaining
52.7% cf. 51.8%). The nal step (441.8–806.1 C) correlated with
a weight loss of 7.2% cf. 7.3% expected for the loss of 2S with
2Au remaining (obs., calcd weight remaining 45.4% cf. 44.5%).
The diﬀerence between the decomposition pathway for 1 and
those for 2 and 3 is that there is no clear distinction between the
rst two steps for 2 and 3. Thus, for 2, step 1, between 163.5 and
346.7 C, is accompanied by a weight loss of 55.2% cf. with
60.9% for the concomitant loss calculated for 2Ph3P and (2L–2S)
(obs., calcd weight remaining for 2AuS 44.7% cf. 39.1%), and
step 2, between 346.7 and 815.2 C, having a weight loss of 9.8%
cf. with the theoretical value of 5.5% expected for the loss of 2S
leaving Au (obs., calcd weight remaining for 2Au 35.0%RSC Adv., 2015, 5, 41401–41411 | 41407
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View Article Onlinecf. 33.6%). The values for step 1 in the decomposition of 3 are
onset-end temperatures 160.7 and 422.6 C with 62.7% weight
loss cf. with calculated 62.1% for the loss 2Cy3P and (2L–2S)
(obs., calcd weight remaining for 2AuS 37.2% cf. 37.8%), and for
step 2, 422.6 to 815.2 C with 3.6% weight loss cf. with calcu-
lated 5.3% for the loss 2S (obs., calcd weight remaining for 2Au
33.6% cf. 32.6%).Evaluation of anti-bacterial activity
A total of 24 strains of pathogen were screened in the present
study, and the results of the disk diﬀusion assay are presented
in the Table 4. Compounds 1–3 exhibited variable degrees of
anti-bacterial activity against the clinically important patho-
gens tested; LH2 showed no inhibitory activity toward the
tested bacteria. Of the series, 1 was the most active compound
with complete inhibitory activity against all tested Gram-
positive and Gram-negative pathogens, except P. aeruginosa,
which is only partially inhibited by 1. A partial zone of inhi-
bition is dened as incomplete inhibition of bacterial growth
and the formation of a lm of bacteria on the surface agar. The
Gram-positive bacteria were most susceptible toward 1, with
greater inhibition zones, ranging from 18 to 30 mm,
compared with Gram-negative bacteria, with reduced inhibi-
tion zones, ranging from 7 to 23 mm. Mild anti-bacterial
activities against several Gram-positive bacteria wereTable 4 Anti-bacterial activity measured by zone of inhibition (mm) of 1
Microorganism 1 2
Gram-positive bacteria
B. cereus ATCC10876 22 —
B. subtilis ATCC6633 27 10
E. faecalis ATCC29212 20 9
E. faecium ATCC19434 18 9
L. monocytogenes ATCC19117 20 9
S. aureus (MRSA) ATCC43300 23 9
S. aureus ATCC25923 30 9
S. saprophyticus ATCC15305 30 9
Gram-negative bacteria
A. baumannii ATCC19606 13 —
A. hydrophilla ATCC35654 8 —
C. freundii ATCC8090 8 —
E. aerogenes ATCC13048 7 —
E. cloacae ATCC35030 8 —
E. coli ATCC25922 10 —
K. pneumonia ATCC700603 8 —
P. aeruginosa ATCC27853 14 (T) —
P. mirabilis ATCC25933 8 —
P. vulgaris ATCC13315 14 —
S. typhimurium ATCC14028 9 —
S. paratyphiA ATCC9150 9 —
S. exneri ATCC12022 12 —
S. sonnei ATCC9290 10 —
S. maltophilia ATCC13637 9 —
V. parahaemolyticus ATCC17802 23 —
a Tetracycline. b Chloramphenicol. c The diameter of inhibition zones in m
zone of inhibition; (T), partial zone of inhibition.
41408 | RSC Adv., 2015, 5, 41401–41411observed for 2 and 3, with clear zones of inhibition ranging
from 7 to 10 mm. Compound 2 was active against all the tested
Gram-positive bacteria except B. cereus. By contrast, 3 exhibi-
ted the lowest activity of the series, being potent in only ve of
eight strains of Gram-positive bacteria, i.e. B. subtilis, E. fae-
cium, L. monocytogenes, MRSA and S. saprophyticus. Clearly, in
this preliminary anti-bacterial assay, the tested Gram-positive
bacteria are more susceptible than Gram-negative bacteria.
This nding is also supported by studies which reported that
Gram-negative bacteria are less susceptible to anti-microbial
agents34 and is consistent with results obtained recently for
mononcuclear phosphanegold(I) analogues.11 The presence of
the outer lipopolysaccharide layer in Gram-negative bacteria
inhibits the access of most drugs to intracellular targets in
bacteria and renders Gram-negative bacteria less susceptible
to drugs than Gram-positive bacteria, which lack an outer
membrane.35
Using the broth micro-dilution method, the anti-bacterial
sensitivity of 1–3 was quantitatively assessed by determining
the minimum inhibitory concentration (MIC), dened as the
highest dilution at which no bacterial growth was detected,
Table 5. A lower MIC value indicates a better anti-microbial
agent as a smaller amount of trial compound is required to
inhibit bacterial growth. Compound 1 exhibited excellent
inhibitory activity toward all susceptible Gram-positive
bacteria compared with 2 and 3, and standard anti-biotics–3, LH2 and standard anti-biotics
c
3 LH2 Standard anti-biotics
— — 11a
8 — 24a
— — 11a
8 — 16b
8 — 27a
7 — 14b
— — 18b
8 — 29a
— — 16a
— — 22a
— — 26a
— — 20a
— — 20a
— — 18a
— — 13a
— — 14a
— — 14b
— — 19b
— — 24a
— — 22a
— — 18a
— — 19a
— — 23b
— — 30a
illimetres (mm) were measured in the disc aer 24 h incubation;—, no
This journal is © The Royal Society of Chemistry 2015
Table 5 MIC and MBC of 1–3, LH2 and standard anti-biotics against selected Gram-positive and Gram-negative bacteria
c
Microorganism
1 2 3 Standard anti-biotics
MIC MBC/MIC MIC MBC/MIC MIC MBC/MIC MIC MBC/MIC
Gram-positive bacteria
B. cereus ATCC10876 0.10 1 — — — — 6.25a 1
B. subtilis ATCC6633 0.20 1 0.78 1 25.00 1 0.20a 1
E. faecalis ATCC29212 0.39 1 6.25 1 — — 12.50a 1
E. faecium ATCC19434 0.20 32 3.13 4 6.25 4 12.50b ND
L. monocytogenes ATCC19117 0.10 1 1.56 1 6.25 1 12.50a 1
S. aureus (MRSA) ATCC43300 0.10 2 1.56 1 50.00 1 12.50b 1
S. aureus ATCC25923 0.10 2 3.13 1 — — 12.50b 1
S. saprophyticus ATCC15305 0.10 2 1.56 1 6.25 2 0.39a ND
Gram-negative bacteria
A. baumannii ATCC19606 6.25 1 — — — — 0.39a 32
A. hydrophilla ATCC35654 6.25 2 — — — — 0.39a 1
C. freundii ATCC8090 25.00 4 — — — — 0.78a 32
E. aerogenes ATCC13048 25.00 4 — — — — 1.56a 32
E. cloacae ATCC35030 25.00 1 — — — — 1.56a ND
E. coli ATCC25922 12.50 1 — — — — 0.39a ND
K. pneumoniae ATCC700603 50.00 ND — — — — 12.50a ND
P. aeruginosa ATCC27853 — — — — — — 6.25a ND
P. mirabilis ATCC25933 12.50 2 — — — — 12.50b 8
P. vulgaris ATCC13315 3.13 4 — — — — 12.50b 4
S. typhimurium ATCC14028 12.50 1 — — — — 1.56a 32
S. paratyphi a ATCC9150 12.50 1 — — — — 1.56a 32
S. exneri ATCC12022 6.25 1 — — — — 0.78a 32
S. sonnei ATCC9290 6.25 2 — — — — 0.78a 32
S. maltophilia ATCC13637 3.13 4 — — — — 3.13b ND
V. parahaemolyticus ATCC17802 1.56 1 — — — — 0.10a 1
a Tetracycline. b Chloramphenicol. c MIC –minimum inhibitory concentration (mg ml1); MBC/MIC ratio for bacteriostatic or bactericidal activity; –
not applicable; ND – not determined as the bacterium had grown across all tested dilution (MBC > 100 mg ml1).
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View Article Online(tetracycline and chloramphenicol), with lowest MIC values in
the range 0.10–0.39 mg ml1. The most susceptible Gram-
positive bacteria strains toward 1 were B. cereus, L. mono-
cytogenes, MRSA, S. aureus and S. saprophyticus (MIC's ¼ 0.10
mg ml1) follow by B. subtilis and E. faecium (MIC's ¼ 0.20 mg
ml1) and E. faecalis (MIC ¼ 0.39 mg ml1). However, tetracy-
cline and chloramphenicol showed equal or, normally, greater
anti-bacterial activity toward Gram-negative bacteria
compared to 1, with lower MIC values in the range 0.10–12.5
mg ml1. Compound 2 exhibited more promising MIC values
(0.78–6.25 mg ml1) than 3 (6.25–50.00 mg ml1) toward
susceptible Gram-positive bacteria. In addition, 2 displayed
greater activity compared with tetracycline and chloram-
phenicol against E. faecalis, E. faecium, L. monocytogenes,
MRSA and S. aureus, with lower MIC values in the range 1.56–
6.25 mg ml1.
The zone of inhibition and MIC tests may reect temporary
inhibition of bacterial growth (bacteriostatic) or bacterial killing
(bactericidal) by a test compound. The bactericidal properties of
1–3 against susceptible strains were further analyzed by the
minimum bactericidal concentration (MBC) assay and
summarized as MBC/MIC ratios in Table 5. An anti-microbial
agent is bactericidal if the MBC is not more than fourfold
higher than the MIC, i.e. MBC/MIC # 4. By contrast, the anti-This journal is © The Royal Society of Chemistry 2015microbial agent is bacteriostatic if the MBC is more than four-
fold greater than the MIC, i.e. MBC/MIC # 4.36 Compounds 2
and 3 were shown to be bactericidal (MBC/MIC # 4) toward the
susceptible Gram-positive bacteria strains. For 1, bactericidal
activity was observed against all susceptible Gram-positive and
Gram-negative bacteria with the exception of E. faecium
(MBC/MIC ¼ 32) and K. pneumoniae (MBC/MIC ¼ ND). These
results suggest that 1–3 are considered bactericidal agents but
the activity of 1 is dependent on the specic bacterial strain.
The broad spectrum of activity exhibited by 1 (R¼ Et) against
Gram-positive and Gram-negative bacteria, and the specic
activity against Gram-positive bacteria exhibited by 2 and 3
suggests a key role for the phosphane ligand. This is vindication
of an earlier study against the same panel of 24 pathogens but
where the thiolate was a dithiocarbamate ligand, i.e. R3PAu
[S2CN(iPr)CH2CH2OH], for R ¼ Et, Ph and Cy.37 In this study a
similar observation was made in that the R ¼ Et derivative had
broad range activity against both Gram-positive and Gram-
negative bacteria, and the activity of the R ¼ Ph and Cy
species was limited to Gram-positive bacteria.37 Perhaps once
thought as being too expensive for development as anti-
microbial agents, the emerging resistance to conventional
therapies suggest that gold compounds may play a clinical role,
especially against virulent strains of bacteria such as MRSA.RSC Adv., 2015, 5, 41401–41411 | 41409
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View Article OnlineConclusions
Three new binuclear phospanegold(I) compounds of a bipodal
ligand have been characterised. Crystallography shows the
uniform adoption of a spherical aggregate featuring unexpected
intramolecular Au/p(aryl) interactions. Theory shows these
interactions to be attractive, providing energies of stabilization
to the molecular structure of 1 greater than 12 kcal mol1
compared to putative Au/O interactions. Compounds 1–3
exhibited, predominantly, a bactericidal eﬀect on Gram-positive
(1–3) and Gram-negative (only 1) pathogens, with 1 perhaps
having potential clinical benets over standard anti-biotics in
bacteriostatic therapy for immune-compromised patients, i.e.
with cancer and neutropenia, by prompt elimination of the
pathogen to therefore reduce the likelihood of the spread of
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